Results 211 to 220 of about 55,011 (304)

State‐Level Variation in Glucagon‐Like Peptide‐1 Receptor Agonists Fills and Spending by Obesity Prevalence, 2023

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Tamkeen Khan   +6 more
doaj   +1 more source

Cardiorenal protective effects of glucagon-like peptide-1 receptor agonists in chronic kidney disease: a systematic review and meta-analysis

open access: gold
Y. Claire Wang   +8 more
openalex   +1 more source

The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe? [PDF]

open access: yesBiomolecules
Kounatidis D   +6 more
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists as potential preventive and therapeutic agents in ischemic stroke

open access: hybrid
Muhammad Ali   +5 more
openalex   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists Versus Bariatric Surgery in Patients With Obesity and Heart Failure With Preserved Ejection Fraction. [PDF]

open access: yesJ Am Heart Assoc
Ibrahim R   +14 more
europepmc   +1 more source

Impact of weight‐loss interventions on psoriasis severity: A systematic review and meta‐analysis

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Weight‐loss interventions were associated with clinically and statistically significant improvements in psoriasis severity (PASI and PASI 75) and quality of life (DLQI). These findings support the role of weight‐loss interventions as effective adjuncts to medical therapy and their integration into holistic psoriasis care.
Sarah Morrow   +6 more
wiley   +1 more source

Glucagon-like Peptide-1 Receptor Agonists and Risk of Thyroid Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials

open access: hybrid
Dena Osama Khawandanah   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy